Chemical Analyzers

 

The North Regional Contracting Office (NRCO), 6021 5th St, Bldg 1469, Ft Belvoir, VA 22060.

The North Regional Contracting Office (NRCO) seeks information on commercial vendors that are capable of providing Chemical Analyzers with Reagents for Ft Meade, MD, Ft Detrick, MD; Ft Myer, MD; and Aberdeen Proving Ground, MD. 

The Chemical Analyzers must meet the minimum specifications as follows:

a.  Kimbrough Ambulatory Care Clinic, Ft Meade, MD

Reagents:  No reagent preparation

 

Measurement Principles:

1. 
   
2. Direct ISE (Potentiometric)
   
3. Colorimetric/Rate
   
4. Immuno-rate
   
5. Turbidimetric
   
6. Semi-quantitative values for drugs of abuse testing
   

 

Calibration:

1. 
   
2. Must have stable 6 month calibrations
   
3. Must be able to pre-calibrate unlimited number of lots
   

 

Instrument Start-Up Requirements:

1. 
   
2. No priming
   
3. No washes
   
4. No daily calibrations
   

 

Sample Types:

1. 
   
2. Serum
   
3. Plasma
   
4. Urine
   
5. CSF
   

 

Sample and Reagent Management:

1. 
   
2. Clot and bubble detection
   
3. High sample viscosity detection
   
4. Save-the-sample management system
   
5. Liquid level sensing
   
6. Reagent delivery detection and management
   

 

On-Board Test Capacity:

1. 
   
2. Must be able to house all current assays packs plus a spare
   
3. Must be able to load packs while instrument is running
   

 

Sample Capacity:

1. 
   
2. Must be able to load >100 samples
   
3. Must have dedicated  STAT lane
   

 

Other considerations:

1. 
   
2. System should scan for sample interferences (hemolysis, icterus, turbidity) with no additional reagents, sample or consumables required.  Scan should have no impact on the delivery of results.  Scan should automatically flag the impacted test results.
   
3. System should not require water or drains that have additional maintenance and cost and carry the potential for contamination risks that impact test results.
   
4. System should have no fixed probes or mixing assemblies that have the potential for carry-over.
   
5. Disposable Tips on both clinical chemistry and Immunochemistry analyzers.
   
6. System should have HDL, LDL, TIBC, HBA1C assays which require no pretreatment.
   
7. System should be capable of performing the following assays:
   1. 
      
   2. HBA1Cs
      
   3. Drugs of Abuse (Amphetamines, Barbituates, Benzodiazepines, Cocaine Metabolites, Methadone, PCP, THC, Opiate, MDMA, Oxycodone)
      
   4. PSA
      
   5. Ferritin
      
   6. HDL
      
   7. LDL
      
   8. Free T3
      
   9. Free T4
      
   10. TIBC
       
   11. Microalbumin
       
   
   

 

b.  Kirk USAHC and Barquist AHC

 

Reagents:  No reagent preparation

 

Measurement Principles:

1. 
   
2. Direct ISE (Potentiometric)
   
3. Colorimetric/Rate
   
4. Immuno-rate
   
5. Turbidimetric
   
6. Semi-quantitative values for drugs of abuse testing
   

 

Calibration:

1. 
   
2. Must have stable 6 month calibrations
   
3. Must be able to pre-calibrate unlimited number of lots
   

 

Instrument Start-Up Requirements:

1. 
   
2. No priming
   
3. No washes
   
4. No daily calibrations
   

 

Sample Types:

1. 
   
2. Serum
   
3. Plasma
   
4. Urine
   
5. CSF
   

 

Sample and Reagent Management:

1. 
   
2. Clot and bubble detection
   
3. High sample viscosity detection
   
4. Save-the-sample management system
   
5. Liquid level sensing
   
6. Reagent delivery detection and management
   

 

On-Board Test Capacity:

1. 
   
2. Must be able to house all current assays packs plus a spare
   
3. Must be able to load packs while instrument is running
   

 

Sample Capacity:

1. 
   
2. Must be able to load >100 samples
   
3. Must have dedicated  STAT lane
   

 

Other considerations:

1. 
   
2. System should scan for sample interferences (hemolysis, icterus, turbidity) with no additional reagents, sample or consumables required.  Scan should have no impact on the delivery of results.  Scan should automatically flag the impacted test results.
   
3. System should not require water or drains that have additional maintenance and cost and carry the potential for contamination risks that impact test results.
   
4. System should have no fixed probes or mixing assemblies that have the potential for carry-over.
   
5. Disposable Tips on both clinical chemistry and Immunochemistry analyzers.
   
6. System should have HDL, LDL, TIBC, HBA1C assays which require no pretreatment.
   
7. System should be capable of performing the following assays:
   1. 
      
   2. HBA1Cs
      
   3. Drugs of Abuse (Amphetamines, Barbituates, Benzodiazepines, Cocaine Metabolites, Methadone, PCP, THC, Opiate, MDMA, Oxycodone)
      
   4. HDL
      
   5. LDL
      
   6. TIBC
      
   7. Microalbumin
      
   
   

 

c.  Rader AHC

 

Reagents:  No reagent preparation

 

Measurement Principles:

1. 
   
2. Direct ISE (Potentiometric)
   
3. Colorimetric/Rate
   
4. Immuno-rate
   

 

Calibration:

1. 
   
2. Must have stable 6 month calibrations
   
3. Must be able to pre-calibrate unlimited number of lots
   

 

Instrument Start-Up Requirements:

1. 
   
2. No priming
   
3. No washes
   
4. No daily calibrations
   

 

Sample Types:

1. 
   
2. Serum
   
3. Plasma
   
4. Urine
   
5. CSF
   

 

Sample and Reagent Management:

1. 
   
2. Clot and bubble detection
   
3. High sample viscosity detection
   
4. Save-the-sample management system
   
5. Liquid level sensing
   
6. Reagent delivery detection and management
   

 

On-Board Test Capacity:

1. 
   
2. Must be able to house all current assays packs plus a spare
   
3. Must be able to load packs while instrument is running
   

 

Sample Capacity:

1. 
   
2. Must be able to load >100 samples
   

 

Other considerations:

1. 
   
2. System should scan for sample interferences (hemolysis, icterus, turbidity) with no additional reagents, sample or consumables required.  Scan should have no impact on the delivery of results.  Scan should automatically flag the impacted test results.
   
3. System should not require water or drains that have additional maintenance and cost and carry the potential for contamination risks that impact test results.
   
4. System should have no fixed probes or mixing assemblies that have the potential for carry-over.
   
5. Disposable tips on both clinical chemistry and Immunochemistry analyzers.
   

 

After results of this market research are obtained NRCO may conduct a competitive procurement and subsequently award a Contract.  If at least two responsible, qualified respondents are classified as small business described herein, then any competitive procurement solicited by NRCO will be done as a small business set-aside.

 

NRCO is seeking responses from all responsible sources, including large, foreign, and small businesses.  Small businesses are defined under the associated NAICS code for this effort, 325413, as those domestic sources having 500 employees or less.  Please include your company's size classification in any response to this notice. 

Companies that can provide the chemical analyzers with reagents are requested to email a detailed report describing their abilities to katherine.a.rowe2.ctr@amedd.army.mil no later than the response date for this sources sought notice.  The report should include achievable qualifications and any other information relevant to your equipments capabilities.  Also, the following information is requested to be provided as part of the response to this sources sought notice: 1. Name of the company, POC name, phone number, address and email address; 2. NAICs code; 3. Descibe the experience your company has in managing similar program(s). 4. Any other relevant information that is not listed above which the Government should consider in developing its minimum requirements and finalizing its market research.

Point of Contact

katherine.a.rowe2.ctr@amedd.army.mil, Contract Specialist, Phone (703) 806-0185, Email katherine.a.rowe2.ctr@amedd.army.mil and Yvonne Parson, Contracting Officer, Phone (703) 806-0140.

 

The North Regional Contracting Office (NRCO), 6021 5th St, Bldg 1469, Ft Belvoir, VA 22060.

The North Regional Contracting Office (NRCO) seeks information on commercial vendors that are capable of providing Chemical Analyzers with Reagents for Ft Meade, MD, Ft Detrick, MD; Ft Myer, MD; and Aberdeen Proving Ground, MD. 

The Chemical Analyzers must meet the minimum specifications as follows:

Reagents:  No reagent preparation

Measurement principles:

1. 
   
2. Direct ISE (Potentiometric)
   
3. Colorimetric/Rate
   
4. Immuno-rate
   
5. Turbidimetric
   
6. Semi-quantitative values for drugs of abuse testing
   

Calibration:

1. 
   
2. Must have stable 6 month calibrations
   
3. Must be able to pre-calibrate unlimited number of lots
   

Instrument start-up requirements:

1. 
   
2. No priming
   
3. No washes
   
4. No daily calibrations
   

Sample Types:

1. 
   
2. Serum
   
3. Plasma
   
4. Urine
   
5. CSF
   

Sample and Reagent Management:

1. 
   
2. Clot and bubble detection
   
3. High sample viscosity detection
   
4. Save-the-sample management system
   
5. Liquid level sensing
   
6. Reagent delivery detection and management
   

On-Board Test Capacity:

1. 
   
2. Must be able to house all current assays packs plus a spare
   
3. Must be able to load packs while instrument is running
   

Sample Capacity:

1. 
   
2. Must be able to load >100 samples
   
3. Must have dedicated  STAT lane
   

Other considerations:

1. 
   
2. System should scan for sample interferences (hemolysis, icterus, turbidity) with no additional reagents, sample or consumables required.  Scan should have no impact on the delivery of results.  Scan should automatically flag the impacted test results.
   
3. System should not require water or drains that have additional maintenance and cost and carry the potential for contamination risks that impact test results.
   
4. System should have no fixed probes or mixing assemblies that have the potential for carry-over.
   
5. Disposable Tips on both clinical chemistry and Immunochemistry analyzers.
   
6. Chemical Analyzers must be able to perform dry chemical analysis. 
   

After results of this market research are obtained NRCO may conduct a competitive procurement and subsequently award a Contract.  If at least two responsible, qualified respondents are classified as small business described herein, then any competitive procurement solicited by NRCO will be done as a small business set-aside.

NRCO is seeking responses from all responsible sources, including large, foreign, and small businesses.  Small businesses are defined under the associated NAICS code for this effort, 325413, as those domestic sources having 500 employees or less.  Please include your company's size classification in any response to this notice. 

Companies that can provide the chemical analyzers with reagents are requested to email a detailed report describing their abilities to katherine.a.rowe2.ctr@amedd.army.mil no later than the response date for this sources sought notice.  The report should include achievable qualifications and any other information relevant to your equipments capabilities.  Also, the following information is requested to be provided as part of the response to this sources sought notice: 1. Name of the company, POC name, phone number, address and email address; 2. NAICs code; 3. Descibe the experience your company has in managing similar program(s). 4. Any other relevant information that is not listed above which the Government should consider in developing its minimum requirements and finalizing its market research.

Point of Contact

katherine.a.rowe2.ctr@amedd.army.mil, Contract Specialist, Phone (703) 806-0185, Email katherine.a.rowe2.ctr@amedd.army.mil and Yvonne Parson, Contracting Officer, Phone (703) 806-0140.